These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 31394414)

  • 1. Crucifera sulforaphane (SFN) inhibits the growth of nasopharyngeal carcinoma through DNA methyltransferase 1 (DNMT1)/Wnt inhibitory factor 1 (WIF1) axis.
    Chen L; Chan LS; Lung HL; Yip TTC; Ngan RKC; Wong JWC; Lo KW; Ng WT; Lee AWM; Tsao GSW; Lung ML; Mak NK
    Phytomedicine; 2019 Oct; 63():153058. PubMed ID: 31394414
    [TBL] [Abstract][Full Text] [Related]  

  • 2. XIAP Limits Autophagic Degradation of Sox2 and Is A Therapeutic Target in Nasopharyngeal Carcinoma Stem Cells.
    Ji J; Yu Y; Li ZL; Chen MY; Deng R; Huang X; Wang GF; Zhang MX; Yang Q; Ravichandran S; Feng GK; Xu XL; Yang CL; Qiu MZ; Jiao L; Yang D; Zhu XF
    Theranostics; 2018; 8(6):1494-1510. PubMed ID: 29556337
    [No Abstract]   [Full Text] [Related]  

  • 3. Therapeutic targeting of CBP/β-catenin signaling reduces cancer stem-like population and synergistically suppresses growth of EBV-positive nasopharyngeal carcinoma cells with cisplatin.
    Chan KC; Chan LS; Ip JC; Lo C; Yip TT; Ngan RK; Wong RN; Lo KW; Ng WT; Lee AW; Tsao GS; Kahn M; Lung ML; Mak NK
    Sci Rep; 2015 Apr; 5():9979. PubMed ID: 25897700
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel Hsp90 inhibitor AT13387 induces senescence in EBV-positive nasopharyngeal carcinoma cells and suppresses tumor formation.
    Chan KC; Ting CM; Chan PS; Lo MC; Lo KW; Curry JE; Smyth T; Lee AW; Ng WT; Tsao GS; Wong RN; Lung ML; Mak NK
    Mol Cancer; 2013 Oct; 12(1):128. PubMed ID: 24156782
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reversal of cisplatin sensitization and abrogation of cisplatin-enriched cancer stem cells in 5-8F nasopharyngeal carcinoma cell line through a suppression of Wnt/β-catenin-signaling pathway.
    Sinnung S; Janvilisri T; Kiatwuthinon P
    Mol Cell Biochem; 2021 Apr; 476(4):1663-1672. PubMed ID: 33423190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nigericin selectively targets cancer stem cells in nasopharyngeal carcinoma.
    Deng CC; Liang Y; Wu MS; Feng FT; Hu WR; Chen LZ; Feng QS; Bei JX; Zeng YX
    Int J Biochem Cell Biol; 2013 Sep; 45(9):1997-2006. PubMed ID: 23831840
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Jervine exhibits anticancer effects on nasopharyngeal carcinoma through promoting autophagic apoptosis via the blockage of Hedgehog signaling.
    Chen J; Wen B; Wang Y; Wu S; Zhang X; Gu Y; Wang Z; Wang J; Zhang W; Yong J
    Biomed Pharmacother; 2020 Dec; 132():110898. PubMed ID: 33113432
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD44+ cancer stem-like cells in EBV-associated nasopharyngeal carcinoma.
    Lun SW; Cheung ST; Cheung PF; To KF; Woo JK; Choy KW; Chow C; Cheung CC; Chung GT; Cheng AS; Ko CW; Tsao SW; Busson P; Ng MH; Lo KW
    PLoS One; 2012; 7(12):e52426. PubMed ID: 23285037
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sulforaphane inhibits cancer stem-like cell properties and cisplatin resistance through miR-214-mediated downregulation of c-MYC in non-small cell lung cancer.
    Li QQ; Xie YK; Wu Y; Li LL; Liu Y; Miao XB; Liu QZ; Yao KT; Xiao GH
    Oncotarget; 2017 Feb; 8(7):12067-12080. PubMed ID: 28076844
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of the hypoxia-activated prodrug evofosfamide (TH-302) in nasopharyngeal carcinoma in vitro and in vivo.
    Huang Y; Tian Y; Zhao Y; Xue C; Zhan J; Liu L; He X; Zhang L
    Cancer Commun (Lond); 2018 May; 38(1):15. PubMed ID: 29764490
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epigallocathechin gallate, polyphenol present in green tea, inhibits stem-like characteristics and epithelial-mesenchymal transition in nasopharyngeal cancer cell lines.
    Lin CH; Shen YA; Hung PH; Yu YB; Chen YJ
    BMC Complement Altern Med; 2012 Oct; 12():201. PubMed ID: 23110507
    [TBL] [Abstract][Full Text] [Related]  

  • 12. mTOR activation in immature cells of primary nasopharyngeal carcinoma and anti-tumor effect of rapamycin in vitro and in vivo.
    Yang C; Peng J; Jiang W; Zhang Y; Chen X; Wu X; Zhu Y; Zhang H; Chen J; Wang J; Cho WC; Jin K
    Cancer Lett; 2013 Dec; 341(2):186-94. PubMed ID: 23933173
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LncRNA THOR attenuates cisplatin sensitivity of nasopharyngeal carcinoma cells via enhancing cells stemness.
    Gao L; Cheng XL; Cao H
    Biochimie; 2018 Sep; 152():63-72. PubMed ID: 29959065
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pectolinarigenin Suppresses the Tumor Growth in Nasopharyngeal Carcinoma.
    Wang C; Cheng Y; Liu H; Xu Y; Peng H; Lang J; Liao J; Liu H; Liu H; Fan J
    Cell Physiol Biochem; 2016; 39(5):1795-1803. PubMed ID: 27744436
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interplay of DNA methyltransferase 1 and EZH2 through inactivation of Stat3 contributes to β-elemene-inhibited growth of nasopharyngeal carcinoma cells.
    Wu J; Tang Q; Yang L; Chen Y; Zheng F; Hann SS
    Sci Rep; 2017 Mar; 7(1):509. PubMed ID: 28360411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phenethyl isothiocyanate suppresses cancer stem cell properties in vitro and in a xenograft model.
    Yun JH; Kim KA; Yoo G; Kim SY; Shin JM; Kim JH; Jung SH; Kim J; Nho CW
    Phytomedicine; 2017 Jul; 30():42-49. PubMed ID: 28545668
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gemcitabine synergizes with cisplatin to inhibit nasopharyngeal carcinoma cell proliferation and tumor growth.
    He SW; Zhang Y; Chen L; Luo WJ; Li XM; Chen Y; Huang SY; He QM; Yang XJ; Li YQ; Liu N; Zhao Y; Ma J
    FASEB J; 2021 Oct; 35(10):e21885. PubMed ID: 34478585
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The tumor suppressor Wnt inhibitory factor 1 is frequently methylated in nasopharyngeal and esophageal carcinomas.
    Chan SL; Cui Y; van Hasselt A; Li H; Srivastava G; Jin H; Ng KM; Wang Y; Lee KY; Tsao GS; Zhong S; Robertson KD; Rha SY; Chan AT; Tao Q
    Lab Invest; 2007 Jul; 87(7):644-50. PubMed ID: 17384664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of sterol regulatory element-binding protein 1 (SREBP1)-mediated lipogenesis by the Epstein-Barr virus-encoded latent membrane protein 1 (LMP1) promotes cell proliferation and progression of nasopharyngeal carcinoma.
    Lo AK; Lung RW; Dawson CW; Young LS; Ko CW; Yeung WW; Kang W; To KF; Lo KW
    J Pathol; 2018 Oct; 246(2):180-190. PubMed ID: 29968360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ABT-199-mediated inhibition of Bcl-2 as a potential therapeutic strategy for nasopharyngeal carcinoma.
    Wang Y; Wang Y; Fan X; Song J; Wu H; Han J; Lu L; Weng X; Nie G
    Biochem Biophys Res Commun; 2018 Sep; 503(3):1214-1220. PubMed ID: 30017199
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.